Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells

Oligonucleotides

Volumn 19, Issue 2, 2009, Pages 103-115

  Taetz, Sebastian ^a,c   Bochot, Amélie ^a,b   Surace, Claudio ^a,b,d   Arpicco, Silvia ^d   Renoir, Jack Michel ^a,b   Schaefer, Ulrich F ^c   Marsaud, Véronique ^a,b   Kerdine Roemer, Saadia ^e   Lehr, Claus Michael ^c   Fattal, Elias ^a,b  

^a UNIV PARIS SUD   (France)

^b CNRS   (France)

^c SAARLAND UNIVERSITY   (Germany)

^d UNIVERSITY OF TURIN   (Italy)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; ALCOHOL; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; HERMES ANTIGEN; HYALURONIC ACID; LACTATE DEHYDROGENASE; LIPOFECTAMINE; LIPOPLEX; LIPOSOME; SMALL INTERFERING RNA; TELOMERASE;

ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL TYPE; CHEMICAL MODIFICATION; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONJUGATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG STABILITY; ENZYME ACTIVITY; ENZYME RELEASE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA BINDING; RNA DEGRADATION; TOXICITY TESTING; ZETA POTENTIAL;

EID: 66249123291     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2008.0168     Document Type: Article

References (33)

1. AAGAARD, L., AMARZGUIOUI, M., SUN, G., SANTOS, L.C., EHSANI, A., PRYDZ, H., and ROSSI, J.J. (2007). A facile lentiviral vector system for expression of doxycycline-inducible shRNAs: knockdown of the pre-miRNA processing enzyme Drosha. Mol. Ther. 15, 938-945.
2. BASTOW,E.R.,BYERS,S.,GOLUB,S.B.,CLARKIN,C.E.,PITSILLIDES, A.A., and FOSANG, A.J. (2008). Hyaluronan synthesis and degradation in cartilage and bone. Cell. Mol. Life Sci. 65, 395-413.
3. BATZRI,S.,andKORN,E.D. (1973). Single bilayerliposomes prepared without sonication. Biochim. Biophys. Acta 298, 1015-1019.
4. CARDOSO, A.L., SIMÕES, S., DE ALMEIDA, L.P., PELISEK, J., CULMSEE, C., WAGNER, E., and PEDROSO DE LIMA, M.C. (2007). siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing. J. Gene Med. 9, 170-183.
5. DEVI, G.R. (2006). siRNA-based approaches in cancer therapy. Cancer Gene Ther. 13, 819-829.
6. ELIAZ, R.E., NIR, S., and SZOKA, F.C. (2004). Interactions of hyaluronan-targeted liposomes with cultured cells: modeling of binding and endocytosis. Methods Enzymol. 387, 16-33.
7. ELIAZ, R.E., and SZOKA, F.C., JR. (2001). Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells. Cancer Res. 61, 2592-2601.
8. HERBERT, B.S., HOCHREITER, A.E., WRIGHT, W.E., and SHAY, J.W. (2006). Nonradioactive detection of telomerase activity using the telomeric repeat amplification protocol. Nat. Protoc. 1, 1583-1590.
9. HORNOF, M., DE LA FUENTE, M., HALLIKAINEN, M., TAMMI, R.H., and URTTI, A. (2008). Low molecular weight hyaluronan shielding of DNA/PEI polyplexes facilitates CD44 receptor mediated uptake in human corneal epithelial cells. J. Gene Med. 10, 70-80.
10. HOU, M., XU, D., BJÖRKHOLM, M., and GRUBER, A. (2001). Realtime quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity. Clin. Chem. 47, 519-524.
11. JIANG, G., Park, K., Kim, J., OH, E., KANG, H., PARK, T., and HAHN, S. (2008). Hyaluronic acid - polyethyleneimine conjugate for target specific intracellular delivery of siRNA. Biopolymers 89, 635-642.
12. JOTHY, S. (2003). CD44 and its partners in metastasis. Clin. Exp. Metastasis 20, 195-201.
13. KIM, N.W., and WU, F. (1997). Advances in quantification and characterization of telomerase activity by the telomeric repeat amplication protocol (TRAP). Nucleic Acids Res. 25, 2595-2597.
14. KREMER, J.M., ESKER, M.W., PATHMAMANOHARAN, C., and WIERSEMA, P.H. (1977). Vesicles of variable diameter prepared by a modified injection method. Biochemistry 16, 3932-3935.
15. LEE, H., MOK, H., LEE, S., OH, Y.K., and PARK, T.G. (2007). Targetspecific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. J. Control. Release 119, 245-252.
16. LI, S.-D., and HUANG, L. (2006). Surface-modified LPD nanoparticles for tumor targeting. Ann. N. Y. Acad. Sci. 1082, 1-8.
17. LUO, Y., ZIEBELL, M.R., and PRESTWICH, G.D. (2000). A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells. Biomacromolecules 1, 208-218.
18. LUO, Y., BERNSH AW, N.J., LU, Z.-R., KOPECEK, J., and PRESTWICH, G.D. (2002). Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates. Pharm. Res. 19, 396-402.
19. MA, Z., LI, J., HE, F., WILSON, A., PITT, B., and LI, S. (2005). Cationic lipids enhance siRNA-mediated interferon response in mice. Biochem. Biophys. Res. Commun. 330, 755-759.
20. MEYER, O., KIRPOTIN, D., HONG, K., STERNBERG, B., PARK, J.W., WOODLE, M.C., and PAPAHADJOPOULOS, D. (1998). Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides. J. Biol. Chem. 273, 15621-15627.
21. MOK, H., PARK, J.W., and PARK, T.G. (2007). Antisense oligodeoxynucleotide-conjugated hyaluronic acid/protamine nanocomplexes for intracellular gene inhibition. Bioconjug. Chem. 18, 1483-1489.
22. PEER, D., and MARGALIT, R. (2003). Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models. Int. J. Cancer 108, 780-789.
23. PEER, D., and MARGALIT, R. (2004). Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal Doxorubicin in syngeneic and human xenograft mouse tumor models. Neoplasia (New York, N.Y.) 6, 343-353.
24. PERSENGIEV, S.P., ZHU, X., and GREEN, M.R. (2004). Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10, 12-18.
25. PONTA, H., SHERMAN, L., and HERRLICH, P.A. (2003). CD44: from adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell Biol. 4, 33-45.
26. SCACHERI, P.C., ROZENBLATT-ROSEN, O., CAPLEN, N.J., WOLFSBERG, T.G., UMAYAM, L., LEE, J.C., HUGHES, C.M., SHANMUGAM, K.S., BHATTACHARJEE, A., MEYERSON, M., and COLLINS, F.S. (2004). Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 101, 1892-1897.
27. SCHIFFELERS, R.M., ANSARI, A., XU, J., ZHOU, Q., TANG, Q., STORM, G., MOLEMA, G., LU, P.Y., SCARIA, P.V., and WOODLE, M.C. (2004). Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res. 32, e149.
28. SHAY, J.W., and WRIGHT, W.E. (2006). Telomerase therapeutics for cancer: challenges and new directions. Nat. Rev. Drug Discov. 5, 577-584.
29. SLEDZ, C.A., HOLKO, M., DE VEER, M.J., SILVERMAN, R.H., and WILLIAMS, B.R.G. (2003). Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5, 834-839.
30. SURACE, C., ARPICCO, S., MARSAUD, V., BOUCLIER, C., DUFAŸWOJCICKI, A., CATTEL, L., RENOIR, J.M., AND FATTAL, E. (2009). Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells. submitted.
31. TOUB, N., MALVY, C., FATTAL, E., and COUVREUR, P. (2006). Innovative nanotechnologies for the delivery of oligonucleotides and siRNA. Biomed. Pharmacother. 60, 607-620.
32. TURLEY, E.A., NOBLE, P.W., and BOURGUIGNON, L.Y. (2001). Signaling properties of hyaluronan receptors. J. Biol. Chem. 277, 4589-4592.
33. YERUSHALMI, N., and MARGALIT, R. (1998). Hyaluronic acid-modified bioadhesive liposomes as local drug depots: effects of cellular and fluid dynamics on liposome retention at target sites. Arch. Biochem. Biophys. 349, 21-26.